AU6357199A - Treatment of gastric asthma - Google Patents
Treatment of gastric asthmaInfo
- Publication number
- AU6357199A AU6357199A AU63571/99A AU6357199A AU6357199A AU 6357199 A AU6357199 A AU 6357199A AU 63571/99 A AU63571/99 A AU 63571/99A AU 6357199 A AU6357199 A AU 6357199A AU 6357199 A AU6357199 A AU 6357199A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- gastric asthma
- asthma
- gastric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000006673 asthma Diseases 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10635498P | 1998-10-30 | 1998-10-30 | |
US60106354 | 1998-10-30 | ||
PCT/GB1999/003536 WO2000025766A2 (en) | 1998-10-30 | 1999-10-26 | Use of nk antagonist for treating gastric asthma |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6357199A true AU6357199A (en) | 2000-05-22 |
Family
ID=22310952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU63571/99A Abandoned AU6357199A (en) | 1998-10-30 | 1999-10-26 | Treatment of gastric asthma |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6357199A (en) |
GB (1) | GB9924141D0 (en) |
WO (1) | WO2000025766A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9911017D0 (en) * | 1999-05-13 | 1999-07-14 | Zeneca Ltd | Pharmaceutical compositions |
GB0015246D0 (en) * | 2000-06-22 | 2000-08-16 | Astrazeneca Ab | Method for the treatment of urinary incontinence |
CA2432543A1 (en) * | 2000-12-22 | 2002-07-04 | Takeda Chemical Industries, Ltd. | Combination drugs |
SE0103668D0 (en) * | 2001-11-02 | 2001-11-02 | Astrazeneca Ab | Method for the treatment of overactive leaves |
SE0103795D0 (en) * | 2001-11-02 | 2001-11-02 | Astrazeneca Ab | Compounds and method for the treatment of overactive bladder |
TW200508221A (en) | 2003-06-13 | 2005-03-01 | Astrazeneca Ab | New azetidine compounds |
WO2006121389A1 (en) * | 2005-05-10 | 2006-11-16 | Astrazeneca Ab | Use of a neurokinin-2 receptor antagonist for treating or preventing detrusor overactivity |
AR057828A1 (en) | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | COMPOUNDS DERIVED FROM AZETIDINE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITION |
US8106208B2 (en) | 2006-05-18 | 2012-01-31 | Albireo Ab | Benzamide compounds that act as NK receptor antagonists |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9310066D0 (en) * | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Alkyl substituted heterocycles |
GB9310713D0 (en) * | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
GB9317104D0 (en) * | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
GB9322643D0 (en) * | 1993-11-03 | 1993-12-22 | Zeneca Ltd | Lactam derivatives |
GB9601202D0 (en) * | 1996-01-22 | 1996-03-20 | Pfizer Ltd | Piperidones |
GB9601697D0 (en) * | 1996-01-27 | 1996-03-27 | Pfizer Ltd | Therapeutic agents |
US5697112A (en) * | 1996-11-08 | 1997-12-16 | Glaxo Wellcome Inc. | Therapy pillow useful for treating gastroesophageal reflux disease (gerd) and other applications |
-
1999
- 1999-10-13 GB GBGB9924141.6A patent/GB9924141D0/en not_active Ceased
- 1999-10-26 AU AU63571/99A patent/AU6357199A/en not_active Abandoned
- 1999-10-26 WO PCT/GB1999/003536 patent/WO2000025766A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB9924141D0 (en) | 1999-12-15 |
WO2000025766A3 (en) | 2000-09-21 |
WO2000025766A2 (en) | 2000-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2882299A (en) | Anti-asthma therapy | |
AU7772794A (en) | Treatment of obesity | |
AU5289698A (en) | Gas treatment devices | |
AU1772399A (en) | Well treatment | |
ZA979731B (en) | Treatment of asthma. | |
AU2740899A (en) | Treatment of liquids | |
AU1356201A (en) | Treatment of hyperproliferative disorders | |
AU3065999A (en) | Compositions and methods for treatment of asthma | |
AU6357199A (en) | Treatment of gastric asthma | |
AU1289300A (en) | Diagnosis of gastric and lung disorders | |
AU7750100A (en) | Method for the treatment of obesity | |
AU8451298A (en) | Treatment of fabrics | |
AU6366100A (en) | Novel methods and reagents for the treatment of osteoarthritis | |
AU1940800A (en) | Combination therapy for the treatment of sepsis | |
AU2619199A (en) | Treatment of waxes | |
AU4598400A (en) | Method of treatment | |
AU3817899A (en) | Therapy of atherosclerosis | |
AU2382601A (en) | Novel method of treatment | |
AU6112299A (en) | Treatment of effluents | |
AUPQ373899A0 (en) | Treatment of asthma II | |
AU8557598A (en) | Treatment of fluids | |
AUPQ361499A0 (en) | Treatment of asthma | |
AU5524399A (en) | Inorgasmia treatment | |
EP1158991A4 (en) | Treatment of asthma | |
AUPO108596A0 (en) | Treatment of obesity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |